713-928-2355
Menu
  • Home
  • Practice Areas
    • Buffalo Bayou or SJ River Claim
    • Personal Injury and Dangerous Devices
      • ITC Fire and Chemical Leak, Deer Park, TX
      • 3M Earplug Lawsuit
      • Essure Birth Control Complications
      • Knee Implant Failure
      • Elbow Implant Failure
      • Shoulder Replacement Lawsuit
      • GM and Chevrolet Airbag Recall
      • Transvaginal Mesh or Sling Implant
    • Drug Injury
      • Stopping Gilenya® (fingolimod) May Cause Permanent Disability
      • Invokana © and other SGLT2 Drugs Risk of Fournier Gangrene
      • Invokana® Increased Risk of Leg and Foot Amputations
      • Actos®
      • Shingles Vaccine Lawsuit Zostavax®
      • Januvia® / Byetta®/ Janumet®
      • Pradaxa®
      • Risperdal®
      • Xarelto®
    • Birth Injury
      • Depakote®
      • Dilantin®
      • Paxil®
      • Zofran®
      • Zoloft®
    • Maritime Injury
  • About
    • Victor Longo
  • Testimonials
  • Blog
  • Contact Us
Home / Practice Areas / Drug Injury / Invokana® Increased Risk of Leg and Foot...

Invokana® Increased Risk of Leg and Foot Amputations

  • Home

The US Food and Drug Administration (FDA) has issued a new boxed warning to the label of the type-2 diabetes drugs Invokana® and  Invokamet®. Diabetic foot is a common side effect in people with type-2 diabetes. Diabetes can destroy nerve endings in the feet and harden blood vessels that carry blood to the toes. Ulcers, sores, and infections can be common in the legs and feet of diabetics. If the condition becomes serious and the area does not heal, it sometimes requires amputation.

These medications are manufactured by Janssen and are also known as Canagliflozin. Two clinical trials with large sample groups have shown an increased risk of leg and foot amputations. The studies showed the risk of amputation was approximately 7 amputations per 1,000 patients on Invokana®. With the placebo, there were 3 amputations per 1,000–more than double the risk. The FDA is now requiring Janssen to include new warnings, including the most stringent Black Boxed Warning, to be added to the Invokana® label.

https://www.longolegal.com/wp-content/uploads/2017/06/Invokana-commercial-MP4_WEB.mp4
 

The FDA noted that most of the amputation reports from people taking Invokana® involve toes and the middle foot. However, the study showed that leg amputations above and below the knee did occur. Some patients taking Invokana® had multiple toes or both legs amputated, according to the study.

The Invokana® Studies

The heightened Invokana® warning from the FDA was the result of getting the final results from two trials. The two studies are known as: CANVAS (Canagliflozin Cardiovascular Assessment Study) and CANVAS-R (A Study of the Effects of Canagliflozin on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus). Both Studies showed similar increases in the incidence rate of amputations. They indicated an approximately twice the risk for both leg and foot amputations in for patients taking Invokana®/canagliflozin as compared to those patients who were randomly assigned to receive placebo.

Patients taking Invokana®/Canagliflozin should notify your health care professionals right away if you develop new pain or tenderness, sores or ulcers, or infections in your legs or feet. Talk to your doctor if you have questions or concerns. Please do not stop taking your diabetes medicine without first talking to your health care professional.

Free Legal Consultation

Please call my office if you think you have a claim against the manufacturer of Invokana®. If you call my office, you will speak to me personally. I will listen, assess, and guide you through this process. The consultation is free of charge and completely confidential. You will pay nothing unless we are successful with your claim. All of our agreements are on a contingency fee basis.

Call Victor Longo toll free at 1-855-566-4648 or fill out our contact form for a free consultation today.

LikeBox

Facebook By Weblizar Powered By Weblizar
Phone: 713-928-2355
Fax: 1-713-923-1043
5728 Hood Street
Houston, TX 77023
Disclaimer/Warning This site is a public resource for general information. Nothing in this website should be considered legal advice. Communications by you through this website do not establish an attorney-client relationship. Our professional obligations require that before accepting any new client, we must determine whether any conflicts exist with current or former clients. To inquire about legal representation, please call or email us. An attorney-client relationship will not be created by placing a call or sending an email. Any medical decision is important. You should not stop taking any prescribed medication unless advised to do so by your doctor. Consult your doctor before making any medical decision and do not rely upon this website in making any medical decision. Attorney licensed in Texas. Attorney not certified by the Boards of Legal Specialization in any state. Not all states have board certifications. Attorney Victor Longo is responsible for the content of this advertisement. Representation is not available in all states and Longo Legal, PLLC is not accepting cases in all states. Longo Legal, PLLC may associate with other law firms in other states and jurisdictions as required. Cases will likely be referred to other lawyers for handling. © Copyright 2016 Longo Legal